Cargando…

Therapeutic Targeting of Collective Invasion in Ovarian Cancer

Ovarian cancer is the seventh most commonly diagnosed cancer amongst women and has the highest mortality rate of all gynaecological malignancies. It is a heterogeneous disease attributed to one of three cell types found within the reproductive milieu: epithelial, stromal, and germ cell. Each histoty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moffitt, Laura, Karimnia, Nazanin, Stephens, Andrew, Bilandzic, Maree
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6471817/ https://www.ncbi.nlm.nih.gov/pubmed/30909510 http://dx.doi.org/10.3390/ijms20061466

Ejemplares similares

Chemoresistance is mediated by ovarian cancer leader cells in vitro
por: Karimnia, Nazanin, et al.
Publicado: (2021)

Non-Invasive Fluorescent Monitoring of Ovarian Cancer in an Immunocompetent Mouse Model
por: Wilson, Amy L., et al.
Publicado: (2018)

Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells
por: Moffitt, Laura R., et al.
Publicado: (2020)

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
por: Bilandzic, Maree, et al.
Publicado: (2014)

Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer Cells
por: Bilandzic, Maree, et al.
Publicado: (2019)

DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model
por: Wilson, Amy L., et al.
Publicado: (2021)

TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells
por: Escalona, Ruth M., et al.
Publicado: (2020)

A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer
por: Stephens, Andrew N., et al.
Publicado: (2023)

An Overview of Candidate Therapeutic Target Genes in Ovarian Cancer
por: Alexandrova, Elena, et al.
Publicado: (2020)

Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells
por: Yang, Wookyeom, et al.
Publicado: (2021)

Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer
por: Nemunaitis, John, et al.
Publicado: (2023)

A Current Review of Targeted Therapeutics for Ovarian Cancer
por: Campos, Susana M., et al.
Publicado: (2010)

Therapeutic targets and new directions for antibodies developed for ovarian cancer
por: Bax, Heather J., et al.
Publicado: (2016)

Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets
por: Xie, Kaipeng, et al.
Publicado: (2019)

Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer
por: Lim, Dansaem, et al.
Publicado: (2020)

Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
por: Zong, Xingyue, et al.
Publicado: (2019)

Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
por: Pyragius, Carmen E., et al.
Publicado: (2013)

STAT3 signaling in ovarian cancer: a potential therapeutic target
por: Liang, Renba, et al.
Publicado: (2020)

Cellular Mechanism of Gene Mutations and Potential Therapeutic Targets in Ovarian Cancer
por: Guo, Tao, et al.
Publicado: (2021)

Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting
por: Kim, Hyun Jung
Publicado: (2022)

Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets
por: Qiu, Yumin, et al.
Publicado: (2022)

Glutathione Transferase P1: Potential Therapeutic Target in Ovarian Cancer
por: Simic, Petar, et al.
Publicado: (2022)

Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer
por: Muccioli, Maria, et al.
Publicado: (2012)

Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
por: Karimnia, Vida, et al.
Publicado: (2021)

Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target
por: Nakamura, Koji, et al.
Publicado: (2019)

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
por: Roy, Lynn, et al.
Publicado: (2018)

Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer
por: Nayak, Amruta P., et al.
Publicado: (2018)

Lipid Regulatory Proteins as Potential Therapeutic Targets for Ovarian Cancer in Obese Women
por: Yang, Jing, et al.
Publicado: (2020)

Targeting of RecQ Helicases as a Novel Therapeutic Strategy for Ovarian Cancer
por: Maity, Jyotirindra, et al.
Publicado: (2022)

Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer
por: Matthews, Bayley G., et al.
Publicado: (2021)

FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer
por: Liu, Cassie, et al.
Publicado: (2021)

BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer
por: Clark-Knowles, Katherine V., et al.
Publicado: (2010)

MicroRNA targeting: A novel therapeutic intervention for ovarian cancer
por: Asl, Elmira Roshani, et al.
Publicado: (2023)

Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
por: Amano, Tsukuru, et al.
Publicado: (2021)

Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
por: Latifi, Ardian, et al.
Publicado: (2012)

Pathogenesis and New Therapeutic Targets of Ovarian Cancer
por: Shih, Ie-Ming, et al.
Publicado: (2012)

Therapeutic Inducers of Apoptosis in Ovarian Cancer
por: Binju, Mudra, et al.
Publicado: (2019)

Scope of nanotechnology in ovarian cancer therapeutics
por: Yallapu, Murali M, et al.
Publicado: (2010)

Therapeutic strategies in epithelial ovarian cancer
por: Kim, Ayako, et al.
Publicado: (2012)

Development of Therapeutic Vaccines for Ovarian Cancer
por: Chow, Stephanie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t6p0djg5hls2vak8vkjtoe6ss4